Company profile
Ehouse Global, Inc.
OTC: EHOS · Healthcare · Biotechnology
PublicHQ San Diego, CIK 0001452580Reports USD
#871 of 1,418 Healthcare companies by revenue27th-percentile growth
EA Score
——FH —DQ 8GM —SS 26
v0.1 · 25/100 weight · pillars only
↑ listing tenure, operating margin · ↓ disclosure history, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$2.8M
Employees
2
as of 2026-08-29
Market cap
$10.1k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.0M$1.0M2011
Net income-$2.8M-$2.8M2014
Operating income-$346.3k-$346.3k2013
Total assets$5.8k$5.8k2014
Liabilities$1.1M$1.1M2014
Equity-$1.1M-$1.1M2014
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ehouse Global, Inc.’s revenue?
Ehouse Global, Inc. booked $1.0M in FY2011 revenue, contracting 24% year over year — slower than 73% of Healthcare companies we track, at a -274.7% net margin.
Peers · Healthcare
Marijuana Company of America, Inc.——Dare Bioscience, Inc.36DSintx Technologies, Inc.35D60 Degrees Pharmaceuticals, Inc.34DShattuck Labs, Inc.49DRavenQuest BioMed Inc.——Key facts
CEOJonathan Smith
SectorHealthcare
IndustryBiotechnology
HeadquartersSan Diego, null
ExchangeOTC: EHOS
Employees2
IPO date2013-07-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.